Immunotherapy and Immune-based Therapy

Immune Suppression Increases the Risk of Both OIs and Non-AIDS-related Conditions  - 4/10/07

Lopinavir/Ritonavir Produces Durable Immunological Recovery in HAART-experienced Patients  1/05/07

Daily Use of Recombinant Human Growth Hormone Increases HIV-specific T cell Responses and Interferon-producing CD8 T Cell Responses in Patients on Antiretroviral Therapy - 3/07/06

Discordant Immunologic and Virologic Responses to HAART Are Associated with Increased Risk of Death and Poor Adherence to Therapy - 11/02/05

Immunological Changes after HAART with Lopinavir-Ritonavir in Heavily Pretreated Children - 6/08/05

Granulocyte-macrophage Colony Stimulating Factor (GM-CSF) as an Immune-based Therapy in HIV Infection - 6/08/05

Abacavir, Efavirenz and Didanosine, with or without Hydroxyurea, in HIV-infected Adults Failing Initial Nucleoside/Protease Inhibitor-containing Regimens - 4/20/05

Encouraging Results From Immune-based Therapy Remune Phase II HIV - 3/14/05

AIDS Pioneer Luc Montagnier Calls for Focus on 'Therapeutic' Vaccine - 3/14/05

Hydroxychloroquine, Hydroxyurea and Didanosine as Initial Therapy for HIV Patients with Low Viral Load: A Useful Strategy for Delaying HAART? - 2/09/05

New Drugs and Treatment for Cryptosporidiosis - 1/24/05

Immunological Analysis of Pediatric Patients at Different Stages of HIV Disease - 1/26/05

Interleukin-7 May Flush Out Latent HIV Reservoirs - 1/07/05